AVNS NYSE
Avanos Medical, Inc.
1W: +0.1%
1M: +0.2%
3M: +1.1%
YTD: +123.5%
1Y: +106.4%
3Y: -4.4%
5Y: -27.7%
$24.99
Last traded 2026-07-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-12-13
Earliest Filing
2023-06-08
Latest Filing
target: 2
acquirer: 1
Counterparties (Filed by AVNS)
3 relationshipsCompanies named in AVNS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| SunMed Group Holdings, LLC | — | acquirer | Acquired substantially all assets of Avanos Medical's Respiratory Health business for $110 million in cash. | 2023-06-08 | View |
| OrthogenRx, Inc. | — | target | Target company acquired by Avanos Medical, Inc. in a merger transaction. | 2022-01-21 | View |
| OrthogenRx, Inc. | — | target | Target company in a merger agreement to be acquired by Avent, Inc. for $130 million in cash plus potential contingent co | 2021-12-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-30 | Material Agreement; Termination of Agreement; Acquisition/Disposition; Financial Obligation; Delisti | Agreement Acquisition | View |
| 2026-07-22 | Shareholder Vote; Regulation FD; Exhibits | View | |
| 2026-07-15 | Other Events; Exhibits | View | |
| 2026-07-02 | Regulation FD; Exhibits | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-04-14 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-03-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-02-26 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-02-24 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-05 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-23 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-09-15 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-30 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-28 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-25 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-04-18 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR